Colorectal cancer is the second most common cause of cancer death among American men and women.
Signs and symptoms of underlying colorectal cancer may include unexplained abdominal pain, recent change in bowel habits, constipation, rectal bleeding, poor appetite, weight loss or anemia. Studies have shown that screening programs can detect early-stage colorectal carcinomas when they are most curable. Dr. Parker will discuss advances in the understanding of the molecular events involved in the development of colon cancer that have led to new agents that may prevent the disease. Colorectal cancer is a multidisciplinary disease that requires careful treatment planning and coordination. Advances in the use of chemotherapy and biologic therapy in the treatment of colorectal cancer will be reviewed.